
Scaffold Therapeutics
Developing proprietary asset identification and therapeutic discovery technologies.
Related Content
Scaffold Therapeutics is a hybrid tech therapeutics company that leverages cutting-edge machine learning and current research data to accelerate the discovery of new medicines across a diverse set of disease areas. The company serves pharmaceutical companies, research institutions, and biotech firms, operating primarily in the biotechnology and healthcare markets. Scaffold Therapeutics employs a business model that integrates computational scientific methods and cloud-optimized software development to generate broad and deep opportunity analyses. These analyses highlight areas of risk and suggest potential mitigation strategies, evolving in parallel with ongoing research activities. This approach ensures that experimental research remains aligned with project goals and identifies areas where additional data are needed. The company generates revenue through partnerships, collaborations, and licensing agreements with its clients.
Keywords: drug discovery, machine learning, biotechnology, healthcare, computational science, cloud software, risk analysis, data-driven, research alignment, hybrid therapeutics.